Are the New Nucleos(t)ide Analogs Better than the Old Nucleos(t)ide Analogs?

被引：0
|
作者：
Choi, Jonggi [1 ]
Choi, Won-Mook [1 ]
Lim, Young-Suk [1 ]
机构：
[1] Univ Ulsan, Asan Med Ctr, Dept Gastroenterol, Coll Med, 88, Olymp Ro 43-gil, Seoul 05505, South Korea
来源：
CLINICS IN LIVER DISEASE | 2023年 / 27卷 / 04期
关键词：
Lamivudine; Adefovir; Entecavir; Tenofovir; Hepatitis B; Hepatocellular carcinoma; CHRONIC HEPATITIS-B; TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; DOUBLE-BLIND; ANTIVIRAL THERAPY; VIRUS INFECTION; ENTECAVIR; ALAFENAMIDE; RESISTANCE; PHASE-3;
D O I：
10.1016/j.cld.2023.05.005
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：809 / 818
页数：10
相关论文
共 50 条
  • [31] Value of autotaxin for hepatocellular carcinoma risk assessment in chronic hepatitis B patients treated with nucleos(t)ide analogs
    Hiyama, Yuichi
    Fujino, Hatsue
    Namba, Maiko
    Fujii, Yasutoshi
    Uchikawa, Shinsuke
    Ono, Atsushi
    Nakahara, Takashi
    Murakami, Eisuke
    Kawaoka, Tomokazu
    Miki, Daiki
    Tsuge, Masataka
    Oka, Shiro
    HEPATOLOGY RESEARCH, 2024, 54 (11) : 981 - 992
  • [32] Treatment of chronic hepatitis B with nucleos(t)ide analogues
    Ohishi, Waka
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2012, 42 (03) : 219 - 225
  • [33] Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs
    Daiki Yamashige
    Tetsuya Hosaka
    Fumitaka Suzuki
    Shunichiro Fujiyama
    Yusuke Kawamura
    Hitomi Sezaki
    Norio Akuta
    Masahiro Kobayashi
    Yoshiyuki Suzuki
    Satoshi Saitoh
    Yasuji Arase
    Kenji Ikeda
    Mariko Kobayashi
    Hiromitsu Kumada
    Journal of Gastroenterology, 2021, 56 : 1008 - 1021
  • [34] Nucleos(t)ide analogue therapy: The role of tenofovir alafenamide
    Buti, Maria
    Marcos-Fosch, Cristina
    Esteban, Rafael
    LIVER INTERNATIONAL, 2021, 41 : 9 - 14
  • [35] Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs
    Yamashige, Daiki
    Hosaka, Tetsuya
    Suzuki, Fumitaka
    Fujiyama, Shunichiro
    Kawamura, Yusuke
    Sezaki, Hitomi
    Akuta, Norio
    Kobayashi, Masahiro
    Suzuki, Yoshiyuki
    Saitoh, Satoshi
    Arase, Yasuji
    Ikeda, Kenji
    Kobayashi, Mariko
    Kumada, Hiromitsu
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (11) : 1008 - 1021
  • [36] Increasing Number of Individuals Receiving Hepatitis B nucleos(t)ide Analogs Therapy in Germany, 2008-2019
    Maisa, Anna
    Kollan, Christian
    an der Heiden, Matthias
    van Bommel, Florian
    Cornberg, Markus
    Mauss, Stefan
    Wedemeyer, Heiner
    Schmidt, Daniel
    Dudareva, Sandra
    FRONTIERS IN PUBLIC HEALTH, 2021, 9
  • [37] Postoperative antiviral therapy with nucleos(t)ide analogs for patients with hepatitis B virus-related hepatocellular carcinoma
    Jiang, Jing-Hang
    Zhong, Jian-Hong
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2016, 40 (03) : E29 - E30
  • [38] Exploration of nucleos(t)ide analogs cessation in chronic hepatitis B patients with hepatitis B e antigen loss
    Xue, Yan
    Zhang, Meng
    Li, Tao
    Liu, Feng
    Zhang, Li-Xin
    Fan, Xiao-Ping
    Yang, Bao-Hua
    Wang, Lei
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (14)
  • [39] Is efficacy of tenofovir in nucleos(t)ide analogue-experienced chronic hepatitis B patients comparable to that in nucleos(t)ide analogue-naive patients?
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yoo, Jeong-Ju
    Cho, Yuri
    Lee, Donghyeon
    Lee, Yun Bin
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    HEPATOLOGY, 2015, 62 : 1204A - 1204A
  • [40] Relapse of Chronic Hepatitis B After Discontinuation of Nucleos(t)ide Analogs: Is the Glass Half Full or Half Empty?
    Reijnders, Jurrien G. P.
    Janssen, Harry L. A.
    HEPATOLOGY, 2013, 58 (06) : 1885 - 1887
12345